St. Jude, Abbott Labs Beat Q1 Expectations

By | April 22, 2015

Scalper1 News

Two medical-product giants were rising in the stock market early Wednesday after beating first-quarter expectations. St. Jude Medical (STJ) jumped 6.5% to a new high above 73 after it reported earnings of 91 cents a share, up 6% from the year-earlier quarter and in line with analysts’ consensus. Revenue shrank 1% to $1.345 billion, but that beat consensus by more than $25 million. The company guided Q2 earnings on the high side of consensus at 99 Scalper1 News

Scalper1 News